Form D — Graviton BioScience Corp
0001847048-26-000004 · filed Nov 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $75,000,000
- Reported amount sold
- $5,000,279
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Graviton BioScience Corp
- CIK
- 1847048
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 125 West End Avenue
New York, New York 10023 - Phone
- 646-366-5120
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Samuel D Waksal · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Rui Wu · Executive OfficerNew York, New York Find on LinkedIn ↗
-
David MacMillan · DirectorNew York, New York Find on LinkedIn ↗
-
Ran Nussbaum · DirectorNew York, New York Find on LinkedIn ↗
-
James Boylan · DirectorNew York, New York Find on LinkedIn ↗
-
Dixon Boardman · DirectorNew York, New York Find on LinkedIn ↗
-
Michael Baran · DirectorNew York, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗